These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 24321208)

  • 1. Ursodeoxycholic acid and diets higher in fat prevent gallbladder stones during weight loss: a meta-analysis of randomized controlled trials.
    Stokes CS; Gluud LL; Casper M; Lammert F
    Clin Gastroenterol Hepatol; 2014 Jul; 12(7):1090-1100.e2; quiz e61. PubMed ID: 24321208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of ursodeoxycholic acid on gallstone disease after bariatric surgery: a meta-analysis of randomized control trials.
    Fearon NM; Kearns EC; Kennedy CA; Conneely JB; Heneghan HM
    Surg Obes Relat Dis; 2022 Jan; 18(1):77-84. PubMed ID: 34772614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery: study protocol for a randomized controlled trial (UPGRADE trial).
    Boerlage TCC; Haal S; Maurits de Brauw L; Acherman YIZ; Bruin S; van de Laar AWJM; Moes DE; van Wagensveld BA; de Vries CEE; van Veen R; Schouten R; Dijkgraaf MG; Fockens P; Gerdes VEA; Voermans RP
    BMC Gastroenterol; 2017 Dec; 17(1):164. PubMed ID: 29262795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ursodeoxycholic acid for the prevention of gallstones and subsequent cholecystectomy after bariatric surgery: a meta-analysis of randomized controlled trials.
    Mulliri A; Menahem B; Alves A; Dupont B
    J Gastroenterol; 2022 Aug; 57(8):529-539. PubMed ID: 35704084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of gallstone formation in morbidly obese patients undergoing rapid weight loss: results of a randomized controlled pilot study.
    Wudel LJ; Wright JK; Debelak JP; Allos TM; Shyr Y; Chapman WC
    J Surg Res; 2002 Jan; 102(1):50-6. PubMed ID: 11792152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Ursodeoxycholic Acid in the Prevention of Gallstones Formation in Bariatric Patients-a Systematic Review and Meta-Analysis of Randomised Trials.
    Sharma A; Shanti H; Nageswaran H; Best LMJ; Patel AG
    Obes Surg; 2023 Dec; 33(12):4115-4124. PubMed ID: 37872257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ursodeoxycholic acid in the prevention of gallstone formation after bariatric surgery: a meta-analysis.
    Uy MC; Talingdan-Te MC; Espinosa WZ; Daez ML; Ong JP
    Obes Surg; 2008 Dec; 18(12):1532-8. PubMed ID: 18574646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, Prospective Comparison of Ursodeoxycholic Acid for the Prevention of Gallstones after Sleeve Gastrectomy.
    Adams LB; Chang C; Pope J; Kim Y; Liu P; Yates A
    Obes Surg; 2016 May; 26(5):990-4. PubMed ID: 26342481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ursodeoxycholic Acid in the Prevention of Gallstone Formation After Bariatric Surgery: an Updated Systematic Review and Meta-analysis.
    Magouliotis DE; Tasiopoulou VS; Svokos AA; Svokos KA; Chatedaki C; Sioka E; Zacharoulis D
    Obes Surg; 2017 Nov; 27(11):3021-3030. PubMed ID: 28889240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ursodeoxycholic acid on gallstone formation after bariatric surgery: An updated meta-analysis.
    Ying J; Dai S; Fu R; Hong J; Dai C; Jin Q
    Obesity (Silver Spring); 2022 Jun; 30(6):1170-1180. PubMed ID: 35475596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of Ursodeoxycholic Acid in the Prevention of Cholelithiasis After Sleeve Gastrectomy.
    Coupaye M; Calabrese D; Sami O; Siauve N; Ledoux S
    Obes Surg; 2019 Aug; 29(8):2464-2469. PubMed ID: 30945151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholelithiasis After Sleeve Gastrectomy and Effectiveness of Ursodeoxycholic Acid Treatment.
    Şen O; Türkçapar AG; Yerdel MA
    J Laparoendosc Adv Surg Tech A; 2020 Nov; 30(11):1150-1152. PubMed ID: 32228343
    [No Abstract]   [Full Text] [Related]  

  • 13. [Gallstones following considerable weight loss and recommendations for their prevention].
    Mijnhout GS; Smulders YM; Craanen ME
    Ned Tijdschr Geneeskd; 2004 Jan; 148(4):174-7. PubMed ID: 14974308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ursodeoxycholic acid for the prevention of gall stones after laparoscopic sleeve gastrectomy: a prospective controlled study.
    Salman MA; Salman A; Mohamed US; Hussein AM; Ameen MA; Omar HSE; Elewa A; Hamdy A; Elias AA; Tourky M; Helal A; Mahmoud AA; Aljarad F; Moustafa A; Shaaban HE; Nashaat A; Hussein AM; Omar T; Balamoun H
    Surg Endosc; 2022 Sep; 36(9):6396-6402. PubMed ID: 35020052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for gallstone formation during weight loss.
    Festi D; Villanova N; Colecchia A
    Clin Gastroenterol Hepatol; 2015 Mar; 13(3):613. PubMed ID: 25148763
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of ursodeoxycholic acid therapy on gallstone formation in the morbidly obese during rapid weight loss.
    Worobetz LJ; Inglis FG; Shaffer EA
    Am J Gastroenterol; 1993 Oct; 88(10):1705-10. PubMed ID: 8213711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bezafibrate for primary biliary cirrhosis.
    Rudic JS; Poropat G; Krstic MN; Bjelakovic G; Gluud C
    Cochrane Database Syst Rev; 2012 Jan; 1(1):CD009145. PubMed ID: 22259000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contributions of obesity and weight loss to gallstone disease.
    Everhart JE
    Ann Intern Med; 1993 Nov; 119(10):1029-35. PubMed ID: 8214980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of Ursodeoxycholic Acid for the Prevention of Gallstone Formation After Gastrectomy in Patients With Gastric Cancer: The PEGASUS-D Randomized Clinical Trial.
    Lee SH; Jang DK; Yoo MW; Hwang SH; Ryu SY; Kwon OK; Hur H; Man Yoon H; Eom BW; Ahn HS; Son T; Song KY; Lee HH; Choi MG; An JY; Lee SI; Lee KH; Ahn S; Park YS; Park DJ;
    JAMA Surg; 2020 Aug; 155(8):703-711. PubMed ID: 32584935
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.